Evidence map›Paper›PMID 42445742›Full record

ReviewDrug design, development and therapy2026

Advances in Research on Autophagy in Steroid-Induced Osteonecrosis of the Femoral Head: Dual Regulation of Its Beneficial and Detrimental Effects.

Mingqiang Liu, Jiwei Huang, Guangzhi Zhang, Haiwei Chen, Haiyan Zhao

Abstract readReview
In one paragraph

Review in Drug design, development and therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Mingqiang Liu *The First Clinical College of Medicine, Lanzhou University, Lanzhou, 730000, People's Republic of China.
Jiwei Huang *The First Clinical College of Medicine, Lanzhou University, Lanzhou, 730000, People's Republic of China.
Guangzhi ZhangDepartment of Orthopedics, The Second Hospital of Lanzhou University, Lanzhou, 730000, People's Republic of China.
Haiwei ChenEmergency Orthopedics Department, The Second Hospital of Lanzhou University, Lanzhou, 730000, People's Republic of China.
Haiyan ZhaoThe First Clinical College of Medicine, Lanzhou University, Lanzhou, 730000, People's Republic of China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Steroid-induced osteonecrosis of the femoral head (SONFH) is a common and refractory clinical condition with a complex pathogenesis that remains incompletely understood. As a highly conserved intracellular degradation and recycling pathway, autophagy plays a dual regulatory role in the pathological process of SONFH: moderate activation of autophagy exerts protective effects by clearing damaged organelles and maintaining cellular homeostasis; conversely, excessive or dysfunctional autophagy aggravates cell injury and bone tissue destruction. This narrative review systematically summarizes the dynamics, mechanisms, and regulatory networks of autophagy in SONFH from the perspectives of both beneficial and detrimental autophagy, providing references for a deeper understanding of SONFH and the development of targeted therapies. Furthermore, we explore therapeutic strategies based on the dual nature of autophagy, including precise pharmacological modulation, restoration of autophagic-lysosomal function, combined treatment approaches, and the application of novel biomaterials and targeted delivery systems. By integrating current mechanistic insights and proposing stage-specific regulatory strategies, this review highlights the translational potential of autophagy modulation in SONFH and provides a theoretical foundation for future clinical interventions.

Indexed as

AutophagyFemur Head NecrosisSteroidsAnimalsHumansSteroidsautophagybeneficial autophagydetrimental autophagydichotomous regulationsteroid-induced osteonecrosis of the femoral headtherapeutic targets

Identifiers

PMID42445742
PMCPMC13357048

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.